Oury; Pascal

Patent Applications and Registrations

Patent applications and USPTO patent grants for Oury; Pascal.The latest application filed is for "oral and/or buccal composition in the form of a thin film of a weakly soluble active ingredient, method of preparing same and use of same".

Company Profile

0.20.24

Oury; Pascal - Le Chesnay FR
Oury; Pascal - Chesnay FR
Oury; Pascal - Versailles FR
Oury; Pascal - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Reduction of opioid blood fluctuations Grant 10,111,869 - Herry , et al. October 30, 2	2018-10-30
Oral and/or buccal composition in the form of a thin film of a weakly soluble active ingredient, method of preparing same and use of same Grant 9,603,797 - Herry , et al. March 28, 2	2017-03-28
Oral And/or Buccal Composition In The Form Of A Thin Film Of A Weakly Soluble Active Ingredient, Method Of Preparing Same And Use Of Same App 20150359735 - HERRY; Catherine ; et al.	2015-12-17
Crush-resistant Tablets Intended To Prevent Accidental Misuse And Unlawful Diversion App 20150246035 - CAILLY-DUFESTEL; Vincent ; et al.	2015-09-03
Pharmaceutical Formulation Of Nanonized Fenofibrate App 20140255480 - HERRY; Catherine ; et al.	2014-09-11
Reduction Of Opioid Blood Fluctuations App 20140220127 - HERRY; Catherine ; et al.	2014-08-07
Sublingual coated tablet of fentanyl Grant 8,709,479 - Oury , et al. April 29, 2	2014-04-29
Multilayer orally disintegrating tablet Grant 8,603,525 - Oury , et al. December 10, 2	2013-12-10
Pharmaceutical composition containing fenofibrate and method for the preparation thereof Grant 8,529,952 - Criere , et al. September 10, 2	2013-09-10
Crush-resistant oxycodone tablets intended for preventing accidental misuse and unlawful diversion Grant 8,501,160 - Cailly-Dufestel , et al. August 6, 2	2013-08-06
Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations Grant 8,409,612 - Criere , et al. April 2, 2	2013-04-02
Orally-dispersible multilayer tablet Grant 8,263,126 - Oury , et al. September 11, 2	2012-09-11
Reduction Of Opioid Blood Fluctuations App 20120083506 - Herry; Catherine ; et al.	2012-04-05
Pharmaceutical Formulation Of Nanonised Fenofibrate App 20110311619 - Herry; Catherine ; et al.	2011-12-22
Pharmaceutical composition containing fenofibrate and method for the preparation thereof Grant 7,863,331 - Criere , et al. January 4, 2	2011-01-04
Low Dose Sublingual Tablets Of Opioid Analgesics And Preparation Process App 20100233257 - Herry; Catherine ; et al.	2010-09-16
Pharmaceutical Composition Containing Fenofibrate And Method For The Preparation Thereof App 20100112049 - Criere; Bruno ; et al.	2010-05-06
Crush-Resistant Tablets Intended to Prevent Accidental Misuse and Unlawful Diversion App 20100015223 - Cailly-Dufestel; Vincent ; et al.	2010-01-21
Multilayer Orally Disintegrating Tablet App 20090311320 - Oury; Pascal ; et al.	2009-12-17
Crush-Resistant Oxycodone Tablets Intended For Preventing Accidental Misuse And Unlawful Diversion App 20090011016 - Cailly-Dufestel; Vincent ; et al.	2009-01-08
Sublingual Coated Tablet App 20080226717 - Oury; Pascal ; et al.	2008-09-18
Low Dose Tablets Of Opioid Analgesics And Preparation Process App 20070286900 - Herry; Catherine ; et al.	2007-12-13
Orally-dispersible multilayer tablet App 20070036861 - Oury; Pascal ; et al.	2007-02-15
Morphine sulfate microgranules, method for preparing same and compositions containing same App 20070003620 - Marechal; Dominique ; et al.	2007-01-04
Sublingual coated tablet of fentanyl App 20060210632 - Oury; Pascal ; et al.	2006-09-21
Morphine sulphate microgranules, method for preparing same and compositions containing same Grant 7,063,864 - Marechal , et al. June 20, 2	2006-06-20
Multilayer orodispersible tablet App 20040247677 - Oury, Pascal ; et al.	2004-12-09
Device for coating granules to be administered orally Grant 6,770,298 - Debregeas , et al. August 3, 2	2004-08-03
Pharmaceutical composition containing fenofibrate and method for the preparation thereof App 20040137055 - Criere, Bruno ; et al.	2004-07-15
Sustained-release microgranules containing diltiazem as active principle Grant 6,660,296 - Debregeas , et al. December 9, 2	2003-12-09
Morphine sulfate microgranules, manufacturing process and pharmaceutical preparations App 20030129244 - Debregeas, Patrice ; et al.	2003-07-10
Microgranules containing cisplatin App 20030017210 - Debregeas, Patrice ; et al.	2003-01-23
Sustained-release microgranules containing diltiazem as active principle App 20020182253 - Debregeas, Patrice ; et al.	2002-12-05
Morphine sulfate microgranules, manufacturing process and pharmaceutical preparations Grant 6,482,437 - Debregeas , et al. November 19, 2	2002-11-19
Morphine Sulfate Microgranules, Manufacturing Process And Pharmaceutical Preparations App 20020028246 - DEBREGEAS, PATRICE ; et al.	2002-03-07
Spheroids containing tiagabine, preparation process and pharmaceutical compositions Grant 6,139,877 - Debregeas , et al. October 31, 2	2000-10-31
Spheroids, preparation process and pharmaceutical compositions Grant 6,077,544 - Debregeas , et al. June 20, 2	2000-06-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.